MannKind Corporation
|
 | ||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: Lots of good news.Mike C. and management should be complimented on the Technosphere revenue diversification progress, even with Afrezza not growing as quickly in the recent past. Afrezza insulin market penetration has been "a hard nut to crack", to date, and hopefully, better marketing will prevail. JMHO.
|
||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 16699 | Re: Lots of good news. | UMD86 | 2 | 8/16/2019 1:24:13 PM |
